Literature DB >> 19152249

Prediction of occult nipple-areola complex involvement in breast cancer patients.

K Gulben1, E Yildirim, U Berberoglu.   

Abstract

The aim of this study was to evaluate predictive factors for the nipple-areola complex (NAC) involvement, and to define a subgroup of patients who may benefit from skin-sparing mastectomy with the NAC preservation in breast cancer patients. Univariate and multivariate analyses were carried out in the retrospective data of 397 eligible patients. The NAC involvement was histopathologically proved in 58 (14.6%) of the patients. In the multivariate logistic regression analysis showed that tumor location (central vs peripheral; p<0.0001; hazard ratio [HR], 7.5; 95% confidence interval [CI], 3.4-14.6), number of positive axillary lymph nodes (> or = 10 vs <10; p<0.005; HR, 2.9; CI, 1.3-6.1), and lymphatic vascular invasion (yes vs no; p<0.0001; HR, 3.5; CI, 1.7-7.1) were the most important prognostic factors. Whereas patients with 2 or 3 risk factors were accepted as high-risk group for the NAC involvement, those with no or 1 risk factor was defined as low-risk group. These groups had a 50.0% NAC involvement rate and a 8.1% NAC involvement rate, respectively (p<0.0001). In conclusion, this study showed that patients with 2 or 3 predictive factors had a high risk of the NAC involvement. These risk factors should be taken into consideration in patient selection for skin-sparing mastectomy with the NAC preservation. Key words: nipple-areola complex; involvement; breast cancer; mastectomy.

Entities:  

Mesh:

Year:  2009        PMID: 19152249     DOI: 10.4149/neo_2009_01_72

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  8 in total

1.  Nipple-Sparing Mastectomy - Extended Indications and Limitations.

Authors:  Markus Niemeyera; Johannes Ettla; Birgit Plattnera; Rainer Schmida; Daniel Müllerb; Hans-Günther Machensb; Marion Kiechlea; Stefan Paepkea
Journal:  Breast Care (Basel)       Date:  2010-08-06       Impact factor: 2.860

2.  Tumor-to-Nipple Distance in Selecting Patients for Nipple-sparing Mastectomy.

Authors:  Sharon L Kracoff-Sella; Tanir M Allweis; Inna Bokov; Hadas Kadar-Sfarad; Yehonatan Shifer; Evgenia Golzman; Dana Egozi
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-07-21

Review 3.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

4.  Nipple Areola Complex Involvement in Invasive Carcinoma Breast.

Authors:  Paul Augustine; Soundrarajan Alagu Ramesh; Ramachandran Krishnankutty Nair; Renu Sukumaran; Regi Jose; Kurian Cherian; Madhu Muralee; Iqbal Ahamad
Journal:  Indian J Surg Oncol       Date:  2018-02-08

5.  Nipple-Sparing Mastectomy with Primary Implant Reconstruction: Surgical and Oncological Outcome of 435 Breast Cancer Patients.

Authors:  Zoran Radovanovic; Milan Ranisavljevic; Dragana Radovanovic; Ferenc Vicko; Tatjana Ivkovic-Kapicl; Nenad Solajic
Journal:  Breast Care (Basel)       Date:  2018-06-20       Impact factor: 2.860

6.  Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimens.

Authors:  Jianli Wang; Xiuli Xiao; Jianmin Wang; Naazneen Iqbal; Laurie Baxter; Kristin A Skinner; David G Hicks; Steven I Hajdu; Ping Tang
Journal:  Ann Surg Oncol       Date:  2011-10-18       Impact factor: 5.344

7.  A nomogram based on clinical factors for preoperative prediction of nipple involvement in breast cancer.

Authors:  Weiling Huang; Zhikun Qiu; Tai Mu; Xi Li
Journal:  Front Surg       Date:  2022-08-11

8.  Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI.

Authors:  Jang Yoo; Bom Sahn Kim; Jin Chung; Hai-Jeon Yoon
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.